PL1830850T3 - Pochodne chinoliny do leczenia gruźlicy utajonej - Google Patents

Pochodne chinoliny do leczenia gruźlicy utajonej

Info

Publication number
PL1830850T3
PL1830850T3 PL05815816T PL05815816T PL1830850T3 PL 1830850 T3 PL1830850 T3 PL 1830850T3 PL 05815816 T PL05815816 T PL 05815816T PL 05815816 T PL05815816 T PL 05815816T PL 1830850 T3 PL1830850 T3 PL 1830850T3
Authority
PL
Poland
Prior art keywords
treatment
quinoline derivatives
latent tuberculosis
tuberculosis
latent
Prior art date
Application number
PL05815816T
Other languages
English (en)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1830850(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL1830850T3 publication Critical patent/PL1830850T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
PL05815816T 2004-12-24 2005-12-08 Pochodne chinoliny do leczenia gruźlicy utajonej PL1830850T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04078529 2004-12-24
EP05105008 2005-06-08
EP05815816A EP1830850B1 (en) 2004-12-24 2005-12-08 Quinoline derivatives for the treatment of latent tuberculosis
PCT/EP2005/056594 WO2006067048A1 (en) 2004-12-24 2005-12-08 Quinoline derivatives for the treatment of latent tuberculosis

Publications (1)

Publication Number Publication Date
PL1830850T3 true PL1830850T3 (pl) 2011-07-29

Family

ID=35717702

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05815816T PL1830850T3 (pl) 2004-12-24 2005-12-08 Pochodne chinoliny do leczenia gruźlicy utajonej

Country Status (31)

Country Link
US (1) US20060142279A1 (pl)
EP (1) EP1830850B1 (pl)
CN (1) CN103142595B (pl)
AP (1) AP2327A (pl)
AR (1) AR051790A1 (pl)
AT (1) ATE501721T1 (pl)
AU (1) AU2005242138B2 (pl)
BR (1) BRPI0506400B8 (pl)
CA (1) CA2529265C (pl)
CR (1) CR9267A (pl)
CY (1) CY1112247T1 (pl)
DE (1) DE602005026984D1 (pl)
DK (1) DK1830850T3 (pl)
EE (1) EE05394B1 (pl)
HK (1) HK1186125A1 (pl)
HR (1) HRP20110392T1 (pl)
IL (1) IL184123A (pl)
LV (1) LV13469B (pl)
ME (1) ME01207B (pl)
MY (1) MY145845A (pl)
NI (1) NI200700146A (pl)
NO (1) NO340376B1 (pl)
NZ (1) NZ555460A (pl)
PA (1) PA8654801A1 (pl)
PL (1) PL1830850T3 (pl)
PT (1) PT1830850E (pl)
RS (1) RS51730B (pl)
SI (1) SI1830850T1 (pl)
TR (1) TR200504892A1 (pl)
TW (1) TWI404535B (pl)
WO (1) WO2006067048A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2301544T3 (da) * 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
UA88701C2 (ru) * 2005-06-28 2009-11-10 Янссэн Фармацэвтика Н.В. Производные хинолина как антибактериальные агенты
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
CA2711912A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
CA2751892A1 (en) 2009-01-15 2010-07-22 Rutgers, The State University Of New Jersey Benzo [c] phenanthridines as antimicrobial agents
WO2010127307A1 (en) 2009-04-30 2010-11-04 Rutgers, The State University Of New Jersey Antimicrobial agents
CA2810162A1 (en) 2010-06-09 2011-12-15 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2011163610A2 (en) * 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
US9475783B2 (en) 2012-03-21 2016-10-25 Rutgers, The State University Of New Jersey Antimicrobial agents
MX358506B (es) 2012-04-27 2018-08-22 Janssen Pharmaceutica Nv Derivados de quinolina antibacterianos.
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
RS64308B1 (sr) 2015-01-27 2023-07-31 Janssen Pharmaceutica Nv Disperzibilni sastavi
US10513528B2 (en) 2016-02-25 2019-12-24 Taxis Pharmaceuticals, Inc. Synthetic processes and intermediates
CN109069514B (zh) * 2016-03-07 2023-12-29 结核病药物开发全球联盟公司 抗菌化合物及其用途
RU2629369C1 (ru) * 2016-10-05 2017-08-29 Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
US10774093B2 (en) 2017-03-30 2020-09-15 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
HUE064651T2 (hu) 2017-07-14 2024-04-28 Janssen Pharmaceutica Nv A bedaquilin késleltetett hatású formulái
RU2661151C1 (ru) * 2017-12-14 2018-07-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
US20220062319A1 (en) 2019-01-09 2022-03-03 Janssen Pharmaceutica Nv Combination in the treatment of nontuberculous mycobacterial diseases
CN115776882A (zh) 2020-07-09 2023-03-10 詹森药业有限公司 长效配制品
WO2022008643A1 (en) 2020-07-09 2022-01-13 Janssen Pharmaceutica Nv Long-acting formulations
KR20230107275A (ko) 2020-11-12 2023-07-14 얀센 파마슈티카 엔.브이. 비결핵성 마이코박테리아 질환의 치료에서 베다퀼린, 에탐부톨 및 마크롤라이드의 조합물
WO2023232838A1 (en) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bedaquiline for use in the treatment of leprosy
WO2024068693A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
WO2024068699A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DK2301544T3 (da) * 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer

Also Published As

Publication number Publication date
PT1830850E (pt) 2011-05-31
EP1830850B1 (en) 2011-03-16
AR051790A1 (es) 2007-02-07
AU2005242138A1 (en) 2006-07-13
CA2529265C (en) 2014-02-11
TR200504892A1 (tr) 2010-04-21
CN103142595B (zh) 2015-05-06
TW200637551A (en) 2006-11-01
CR9267A (es) 2008-09-09
ATE501721T1 (de) 2011-04-15
ME01207B (me) 2013-03-20
AU2005242138B2 (en) 2011-05-26
NO20073823L (no) 2007-07-23
HK1186125A1 (en) 2014-03-07
BRPI0506400A8 (pt) 2017-09-12
AP2007004054A0 (en) 2007-06-30
WO2006067048A1 (en) 2006-06-29
NZ555460A (en) 2008-11-28
DE602005026984D1 (de) 2011-04-28
AP2327A (en) 2011-11-25
RS51730B (en) 2011-10-31
NI200700146A (es) 2019-05-10
LV13469B (en) 2007-01-20
CA2529265A1 (en) 2006-06-24
CY1112247T1 (el) 2015-12-09
SI1830850T1 (sl) 2011-07-29
DK1830850T3 (da) 2011-06-14
IL184123A0 (en) 2008-12-29
US20060142279A1 (en) 2006-06-29
MY145845A (en) 2012-04-30
CN103142595A (zh) 2013-06-12
EP1830850A1 (en) 2007-09-12
BRPI0506400B8 (pt) 2021-05-25
BRPI0506400A (pt) 2006-08-29
HRP20110392T1 (hr) 2011-06-30
EE05394B1 (et) 2011-04-15
PA8654801A1 (es) 2006-08-03
TWI404535B (zh) 2013-08-11
IL184123A (en) 2011-10-31
BRPI0506400B1 (pt) 2021-04-06
NO340376B1 (no) 2017-04-10
EE200500033A (et) 2006-08-15

Similar Documents

Publication Publication Date Title
HK1186125A1 (en) Quinoline derivatives for the treatment of latent tuberculosis
AP2037A (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
PT1802579E (pt) Derivados da 3-arilaminopiridina
HK1096083A1 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
HK1098155A1 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
HK1104235A1 (en) S-mirtazapine for the treatment of hot flush
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
ZA200705160B (en) Quinoline derivatives for the treatment of latent tuberculosis
ZA200800921B (en) Pyrazolone derivatives for the treatment of tuberculosis
ZA200608015B (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0408297D0 (en) Indole derivatives for the treatment of diseases
GB0412299D0 (en) Method for the synthesis of halogenated heterocycles
IL176564A0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases